Global Spinal Cord Stimulation Devices Market Research Report 2021

A Spinal Cord Stimulator (SCS) or Dorsal Column Stimulator (DCS) is a type of implantable neuromodulation device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the spinal cord (dorsal columns) for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy.
The classification of spinal cord stimulation devices includes rechargeable type and non-rechargeable type. The proportion of rechargeable type in 2019 is about 69%, and the proportion is in increasing trend from 2015 to 2019.
Spinal cord stimulation devices are widely used in Hospitals and Ambulatory Surgery Centers. The most proportion of spinal cord stimulation devices is used in Hospitals, and the proportion in 2019 is 71%.
North America is the largest consumption place, with a consumption market share nearly 57.7% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 24%.
Market competition is intense. Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro, Nuvectra are the leaders of the industry. And top 3 account for around 79% of the total market share. These existing companies are making investments in several research activities to launch new devices.

The global Spinal Cord Stimulation Devices market was valued at US$ 2399.1 million in 2019 and is expected to reach US$ 3453 million by the end of 2026, growing at a CAGR of 6.6% during 2021-2026.
This report focuses on Spinal Cord Stimulation Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Spinal Cord Stimulation Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Spinal Cord Stimulation Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Rechargeable SCS
Non-Rechargeable SCS

Segment by Application
Hospitals
Ambulatory Surgery Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Medtronic
Boston Scientific
Abbott (St. Jude Medical)
Nevro
Nuvectra